Additionally, studies have reported that PIK3 CA, TERT, and KRAS genes often exhibit methylation-mediated silencing in various cancer types [59–61], including thyroid cancer, contributing to the development of a malignant phenotype. This evidence concerns the gene KRAS and cancer.